Treatment Choices

From Patient to Participant

When Teresa Singh was diagnosed with non-Hodgkin's lymphoma in 1996, her oncologist recommended the standard course of treatment: a combination of chemotherapy and radiation. But in researching her disease, Singh learned the likelihood of her cancer returning within 18 months was high. And if a recurrence was treated successfully, it was still likely to come back yet again. Standard treatment just didn't seem like the right choice for Singh, so she started looking for other options.